Sanofi’s Acomplia Copied in India
Seems three Indian companies have already moved to copy Sanofi’s Acomplia (rimonabant) before it is even for sale in Europe and the US. The companies identified are Sun Pharmaceuticals, Torrent Pharma and Zydus Cadila.
Sanofi’s Acomplia already copied in India - paper:
It should be noted that India patent law does not require them to respect patents on drugs developed prior to 1995. The claim is that these companies are only making it for the Indian market but I find this suspect. Once sold in India, it will be hard to control its sales to other countries. This is likely what these companies are betting on. They are unlikely to go head to head with Sanofi but more likely to throw up their hands and say, we only sold to distributors in India and that they have no control over what happens after that.
Sanofi is exploring legal options but it is not likely to have many from my perspective, provided these companies do only sell in India. If they sell it into other countries they are likely to face legal disputes.
Technorati Tags: Acomplia, Rimonabant, Sanofi-Aventis
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
